Stocksigma LogoStocksigma Logo

Alpa Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

■ Revenue: 3,098 (+18.0% YoY | +29.4% QoQ) ■ EBITDA: -222 (+0.8% YoY | +43.8% QoQ) ■ EBITDA Margin (%): -7.2 (+136 bps YoY | +936 bps QoQ) ■ PAT: -185

Alpa Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs)

Alpa Laboratories Ltd · Outcome · 15 Nov 2026, 12:07 am

Alpa Laboratories Ltd - Financial Result for the Quarter ended 30th Sep'26 (Consolidated, INR Lakhs) ■ Revenue: 3,098 (+18.0% YoY | +29.4% QoQ) ■ EBITDA: -222 (+0.8% YoY | +43.8% QoQ) ■ EBITDA Margin (%): -7.2 (+136 bps YoY | +936 bps QoQ) ■ PAT: -185 (Profit to Loss YoY | Profit to Loss QoQ) ■ EPS (INR): -0.85 (Profit to Loss YoY | Profit to Loss QoQ)

Original exchange filing (PDF)

More announcements from Alpa Laboratories Ltd

All Alpa Laboratories Ltd announcements